Cargando…
Immune Checkpoint Inhibitors in Cancer Therapy—How Can We Improve Clinical Benefits?
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913410/ https://www.ncbi.nlm.nih.gov/pubmed/36765836 http://dx.doi.org/10.3390/cancers15030881 |
| _version_ | 1784885420506480640 |
|---|---|
| author | Baxevanis, Constantin N. |
| author_facet | Baxevanis, Constantin N. |
| author_sort | Baxevanis, Constantin N. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9913410 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | MDPI |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-99134102023-02-11 Immune Checkpoint Inhibitors in Cancer Therapy—How Can We Improve Clinical Benefits? Baxevanis, Constantin N. Cancers (Basel) Editorial MDPI 2023-01-31 /pmc/articles/PMC9913410/ /pubmed/36765836 http://dx.doi.org/10.3390/cancers15030881 Text en © 2023 by the author. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
| spellingShingle | Editorial Baxevanis, Constantin N. Immune Checkpoint Inhibitors in Cancer Therapy—How Can We Improve Clinical Benefits? |
| title | Immune Checkpoint Inhibitors in Cancer Therapy—How Can We Improve Clinical Benefits? |
| title_full | Immune Checkpoint Inhibitors in Cancer Therapy—How Can We Improve Clinical Benefits? |
| title_fullStr | Immune Checkpoint Inhibitors in Cancer Therapy—How Can We Improve Clinical Benefits? |
| title_full_unstemmed | Immune Checkpoint Inhibitors in Cancer Therapy—How Can We Improve Clinical Benefits? |
| title_short | Immune Checkpoint Inhibitors in Cancer Therapy—How Can We Improve Clinical Benefits? |
| title_sort | immune checkpoint inhibitors in cancer therapy—how can we improve clinical benefits? |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913410/ https://www.ncbi.nlm.nih.gov/pubmed/36765836 http://dx.doi.org/10.3390/cancers15030881 |
| work_keys_str_mv | AT baxevanisconstantinn immunecheckpointinhibitorsincancertherapyhowcanweimproveclinicalbenefits |